They classified CRC into 5 subtypes: stem-like, transit amplifying [TA], enterocyte, goblet-like, and inflammatory type, of which the TA type could be further subdivided into 2 sub-groups based on different responses to epidermal growth factor receptor (EGFR)-targeted therapy (8). This evidence concerns the gene EGFR and colorectal carcinoma.